| This article has been cited by |
| 1 | | |
| Salman M. Hyder,Benford Mafuvadze,Cynthia Besch-Williford |
| .2013;()123 |
| [DOI] |
|
| 2 | | |
| Ruchika Kaul-Ghanekar,Snehal Suryavanshi,Prerna Raina |
| .2015;()61 |
| [DOI] |
|
| 3 | Beneficial and detrimental aspects of miRNAs as chief players in breast cancer: A comprehensive review | |
| Ahmed Ismail,Hesham A. El-Mahdy,Ahmed I. Abulsoud,Al-Aliaa M. Sallam,Mahmoud Gomaa Eldeib,Elsayed G.E. Elsakka,Mohamed Bakr Zaki,Ahmed S. Doghish |
| International Journal of Biological Macromolecules.2023;224()1541 |
| [DOI] |
|
| 4 | Transforming growth factor-ß, insulin-like growth factor I/insulin-like growth factor I receptor and vascular endothelial growth factor-A: Prognostic and predictive markers in triple-negative and non-triple-negative breast cancer | |
| ABEER BAHHNASSY,MARWA MOHANAD,SABRY SHAARAWY,MANAL F. ISMAIL,AHMED EL-BASTAWISY,ABEER M. ASHMAWY,ABDEL-RAHMAN ZEKRI |
| Molecular Medicine Reports.2015;12(1)851 |
| [DOI] |
|
| 5 | Thiazole-containing compounds as therapeutic targets for cancer therapy | |
| Prabodh Chander Sharma,Kushal Kumar Bansal,Archana Sharma,Diksha Sharma,Aakash Deep |
| European Journal of Medicinal Chemistry.2020;188(1)112016 |
| [DOI] |
|
| 6 | Molecular Mechanisms and Translational Therapies for Human Epidermal Receptor 2 Positive Breast Cancer | |
| Quanxia Lv,Ziyuan Meng,Yuanyuan Yu,Feng Jiang,Daogang Guan,Chao Liang,Junwei Zhou,Aiping Lu,Ge Zhang |
| International Journal of Molecular Sciences.2016;17(12)2095 |
| [DOI] |
|
| 7 | Molecular Mechanisms and Translational Therapies for Human Epidermal Receptor 2 Positive Breast Cancer | |
| Adnan Aydiner |
| International Journal of Molecular Sciences.2016;17(12)535 |
| [DOI] |
|
| 8 | Euphol arrests breast cancer cells at the G1 phase through the modulation of cyclin D1, p21 and p27 expression | |
| LIN WANG,GUIYING WANG,DANDAN YANG,XUDONG GUO,YANXIN XU,BO FENG,JIUHONG KANG |
| Molecular Medicine Reports.2013;8(4)1279 |
| [DOI] |
|
| 9 | Human Antibody Fusion Proteins/Antibody Drug Conjugates in Breast and Ovarian Cancer | |
| Eden R. Padayachee,Fleury Augustin Nsole Biteghe,Zaria Malindi,Dirk Bauerschlag,Stefan Barth |
| Transfusion Medicine and Hemotherapy.2017;44(5)303 |
| [DOI] |
|
| 10 | Novel Strategies on Personalized Medicine for Breast Cancer Treatment: An Update | |
| Carmen Chan,Bernard Law,Winnie So,Ka Chow,Mary Waye |
| International Journal of Molecular Sciences.2017;18(11)2423 |
| [DOI] |
|
| 11 | Anticancer activity of an ultrasonic nanoemulsion formulation of Nigella sativa L. essential oil on human breast cancer cells | |
| Vaiyapuri Subbarayan Periasamy,Jegan Athinarayanan,Ali A. Alshatwi |
| Ultrasonics Sonochemistry.2016;31(11)449 |
| [DOI] |
|
| 12 | Inhibitor Response to HER2 G776YVMAIn-frame Insertion in HER2-positive Breast Cancer | |
| Ya-Bing Zheng,Yang Yu,Bo Chen,Jin-Lin Hu,Tian Jing,Xi-Ping Zhang |
| Cancer Investigation.2016;34(3)123 |
| [DOI] |
|
| 13 | Using Boolean Logic Modeling of Gene Regulatory Networks to Exploit the Links Between Cancer and Metabolism for Therapeutic Purposes | |
| Osama A. Arshad,Priyadharshini S. Venkatasubramani,Aniruddha Datta,Jijayanagaram Venkatraj |
| IEEE Journal of Biomedical and Health Informatics.2016;20(1)399 |
| [DOI] |
|
| 14 | Lapatinib nano-delivery systems: a promising future for breast cancer treatment | |
| Gunjan Vasant Bonde,Sarita Kumari Yadav,Sheetal Chauhan,Pooja Mittal,Gufran Ajmal,Sathish Thokala,Brahmeshwar Mishra |
| Expert Opinion on Drug Delivery.2018;15(5)495 |
| [DOI] |
|
| 15 | Retrospective review of genomic testing in breast cancer: Does it improve outcome? | |
| Grady M. Gastelum,Cyrus Iqbal,Susan G. Hilsenbeck,Mothaffar F. Rimawi,Polly Niravath |
| Breast Cancer Research and Treatment.2017;163(1)191 |
| [DOI] |
|
| 16 | Thioaptamer-conjugated CD44-targeted delivery system for the treatment of breast cancer in vitro and in vivo | |
| Wei Fan,Xiang Wang,Baoyue Ding,Haimin Cai,Xudong Wang,Yueqi Fan,Yong Li,Shenghui Liu,Suifeng Nie,Qiping Lu |
| Journal of Drug Targeting.2016;24(4)359 |
| [DOI] |
|
| 17 | Breast Cancer Targeted Treatment Strategies: Promising Nanocarrier Approaches | |
| Sivakumar P. Malliappan,Palanivel Kandasamy,Siva Chidambaram,Devanand Venkatasubbu,Sathish K. Perumal,Abimanyu Sugumaran |
| Anti-Cancer Agents in Medicinal Chemistry.2020;20(11)1300 |
| [DOI] |
|
| 18 | Imaging Considerations and Interprofessional Opportunities in the Care of Breast Cancer Patients in the Neoadjuvant Setting | |
| Anna G. Sorace,Sara Harvey,Anum Syed,Thomas E. Yankeelov |
| Seminars in Oncology Nursing.2017;33(4)425 |
| [DOI] |
|
| 19 | IRS1 is highly expressed in localized breast tumors and regulates the sensitivity of breast cancer cells to chemotherapy, while IRS2 is highly expressed in invasive breast tumors | |
| Holly A. Porter,Anthony Perry,Chris Kingsley,Nhan L. Tran,Achsah D. Keegan |
| Cancer Letters.2013;338(2)239 |
| [DOI] |
|
| 20 | Treating Elderly Patients with Hormone Receptor–Positive Advanced Breast Cancer | |
| David Riseberg |
| Clinical Medicine Insights: Oncology.2015;9(2)CMO.S26067 |
| [DOI] |
|
| 21 | Serum Overexpression of MicroRNA-10b in Patients with Bone Metastatic Primary Breast Cancer | |
| F-L Zhao,G-D Hu,X-F Wang,X-H Zhang,Y-K Zhang,Z-S Yu |
| Journal of International Medical Research.2012;40(3)859 |
| [DOI] |
|
| 22 | Experimental Models as Refined Translational Tools for Breast Cancer Research | |
| Eduardo Costa,Tânia Ferreira-Gonçalves,Gonçalo Chasqueira,António S. Cabrita,Isabel V. Figueiredo,Catarina Pinto Reis |
| Scientia Pharmaceutica.2020;88(3)32 |
| [DOI] |
|
| 23 | Safety of Combined Treatment With Monoclonal Antibodies and Viscum album L Preparations | |
| Friedemann Schad,Jan Axtner,Matthias Kröz,Harald Matthes,Megan L. Steele |
| Integrative Cancer Therapies.2018;17(1)41 |
| [DOI] |
|
| 24 | Role of miRNAs in regulating responses to radiotherapy in human breast cancer | |
| Zhi Xiong Chong,Swee Keong Yeap,Wan Yong Ho |
| International Journal of Radiation Biology.2021;97(3)289 |
| [DOI] |
|
| 25 | Yes1 signaling mediates the resistance to Trastuzumab/Lap atinib in breast cancer | |
| Tatsuaki Takeda,Hiromasa Yamamoto,Hirotaka Kanzaki,Ken Suzawa,Takahiro Yoshioka,Shuta Tomida,Xiaojiang Cui,Ramachandran Murali,Kei Namba,Hiroki Sato,Hidejiro Torigoe,Mototsugu Watanabe,Kazuhiko Shien,Junichi Soh,Hiroaki Asano,Kazunori Tsukuda,Yoshihisa Kitamura,Shinichiro Miyoshi,Toshiaki Sendo,Shinichi Toyooka,Ming Tan |
| PLOS ONE.2017;12(2)e0171356 |
| [DOI] |
|
| 26 | Yes1 signaling mediates the resistance to Trastuzumab/Lap atinib in breast cancer | |
| Somia Liaqat,Mubashar Hussain,Kiran Aftab,Maryam Khalid,Saima Shakil Malik |
| PLOS ONE.2022;12(2)367 |
| [DOI] |
|
| 27 | Novel Adamantanyl-Based Thiadiazolyl Pyrazoles Targeting EGFR in Triple-Negative Breast Cancer | |
| Anusha Sebastian,Vijay Pandey,Chakrabhavi Dhananjaya Mohan,Yi Ting Chia,Shobith Rangappa,Jessin Mathai,C. P. Baburajeev,Shardul Paricharak,Lewis H. Mervin,Krishna C. Bulusu,Julian E. Fuchs,Andreas Bender,Shuhei Yamada,Shuhei Basappa,Peter E. Lobie,Kanchugarakoppal S. Rangappa |
| ACS Omega.2016;1(6)1412 |
| [DOI] |
|
| 28 | A Brief Literature and Review of Patents on Thiazole Related Derivatives | |
| Diksha Sharma,Kushal K. Bansal,Archana Sharma,Meenakshi Pathak,Prabodh C. Sharma |
| Current Bioactive Compounds.2019;15(3)304 |
| [DOI] |
|
| 29 | Immunotherapy for Breast Cancer Treatment | |
| Miganoosh Simonian,Mozhan Haji Ghaffari,Babak Negahdari |
| Iranian Biomedical Journal.2021;25(3)140 |
| [DOI] |
|
| 30 | YES1 as a Therapeutic Target for HER2-Positive Breast Cancer after Trastuzumab and Trastuzumab-Emtansine (T-DM1) Resistance Development | |
| Miwa Fujihara,Tadahiko Shien,Kazuhiko Shien,Ken Suzawa,Tatsuaki Takeda,Yidan Zhu,Tomoka Mamori,Yusuke Otani,Ryo Yoshioka,Maya Uno,Yoko Suzuki,Yuko Abe,Minami Hatono,Takahiro Tsukioki,Yuko Takahashi,Mariko Kochi,Takayuki Iwamoto,Naruto Taira,Hiroyoshi Doihara,Shinichi Toyooka |
| International Journal of Molecular Sciences.2021;22(23)12809 |
| [DOI] |
|
| 31 | Molecular biomarkers for prediction of response to treatment and survival in triple negative breast cancer patients from Egypt | |
| Abeer Bahnassy,Marwa Mohanad,Manal F. Ismail,Sabry Shaarawy,Ahmed El-Bastawisy,Abdel-Rahman N. Zekri |
| Experimental and Molecular Pathology.2015;99(2)303 |
| [DOI] |
|
| 32 | Regulation of angiogenic factors by the PI3K/Akt pathway in A549 lung cancer cells under hypoxic conditions | |
| Youbang Xie,Yali Qi,Yanmiao Zhang,Jiayi Chen,Tianyi Wu,Yuhai Gu |
| Oncology Letters.2017;13(5)2909 |
| [DOI] |
|
| 33 | Targeted therapies in breast cancer: New challenges to fight against resistance | |
| Viviana Masoud,Gilles Pagès |
| World Journal of Clinical Oncology.2017;8(2)120 |
| [DOI] |
|
| 34 | Copper complex derived from S-benzyldithiocarbazate and 3-acetylcoumarin induced apoptosis in breast cancer cell | |
| Jhi Biau Foo,May Lee Low,Ji Hui Lim,Yan Zhi Lor,Rusyidah Zainol Abidin,Vilasini Eh Dam,Napsiah Abdul Rahman,Chaw Yee Beh,Lee Chin Chan,Chee Wun How,Yin Sim Tor,Latifah Saiful Yazan |
| BioMetals.2018;31(4)505 |
| [DOI] |
|
| 35 | microRNA-194 suppresses osteosarcoma cell proliferation and metastasis in vitro and in vivo by targeting CDH2 and IGF1R | |
| KANG HAN,TINGBAO ZHAO,XIANG CHEN,NA BIAN,TONGTAO YANG,QIONG MA,CHENGKUI CAI,QINGYU FAN,YONG ZHOU,BAOAN MA |
| International Journal of Oncology.2014;45(4)1437 |
| [DOI] |
|
| 36 | Transcriptional activation of EGFR by HOXB5 and its role in breast cancer cell invasion | |
| Ji-Yeon Lee,Jie Min Kim,Da Som Jeong,Myoung Hee Kim |
| Biochemical and Biophysical Research Communications.2018;503(4)2924 |
| [DOI] |
|
| 37 | Advances in the understanding of the clinically relevant genetic pathways and molecular aspects of canine mammary tumours. Part 2: Invasion, angiogenesis, metastasis and therapy | |
| A.A. Santos,A.J.F. Matos |
| The Veterinary Journal.2015;205(2)144 |
| [DOI] |
|
| 38 | Metabolic Imaging to Assess Treatment Response to Cytotoxic and Cytostatic Agents | |
| Natalie J. Serkova,S. Gail Eckhardt |
| Frontiers in Oncology.2016;6(2)144 |
| [DOI] |
|
| 39 | The interplay between AR, EGF receptor and MMP-9 signaling pathways in invasive prostate cancer | |
| Anna Mandel,Per Larsson,Martuza Sarwar,Julius Semenas,Azharuddin Sajid Syed Khaja,Jenny L. Persson |
| Molecular Medicine.2018;24(1)144 |
| [DOI] |
|
| 40 | Increasing matrix stiffness upregulates vascular endothelial growth factor expression in hepatocellular carcinoma cells mediated by integrin ß1 | |
| Yinying Dong,Xiaoying Xie,Zhiming Wang,Chao Hu,Qiongdan Zheng,Yaohui Wang,Rongxin Chen,Tongchun Xue,Jie Chen,Dongmei Gao,Weizhong Wu,Zhenggang Ren,Jiefeng Cui |
| Biochemical and Biophysical Research Communications.2014;444(3)427 |
| [DOI] |
|
| 41 | The forgotten woman's cancer: vulvar squamous cell carcinoma (VSCC) and a targeted approach to therapy | |
| A.A. Clancy,J.N. Spaans,J.I. Weberpals |
| Annals of Oncology.2016;27(9)1696 |
| [DOI] |
|
| 42 | Selective Targeting of the L858R Mutation (EGFR) in Non-Small Cell Lung Cancer: A Mechanism for Advancing Targeted Chemotherapy | |
| Rohan Arora,Venkat Krishnan |
| Frontiers in Oncology.2017;7(9)1696 |
| [DOI] |
|
| 43 | Identification and validation of a prognostic risk model based on caveolin family genes for breast cancer | |
| Qiang Tang,Shurui Wang,Ziyang Di,Huimin Li,Kailiang Xu,Xin Hu,Maojun Di |
| Frontiers in Cell and Developmental Biology.2022;10(9)1696 |
| [DOI] |
|
| 44 | ‘Lnc’-ing Wnt in female reproductive cancers: therapeutic potential of long non-coding RNAs in Wnt signalling | |
| Mei S Ong,Wanpei Cai,Yi Yuan,Hin C Leong,Tuan Z Tan,Asad Mohammad,Ming L You,Frank Arfuso,Boon C Goh,Sudha Warrier,Gautam Sethi,Nicholas S Tolwinski,Peter E Lobie,Celestial T Yap,Shing C Hooi,Ruby Y Huang,Alan P Kumar |
| British Journal of Pharmacology.2017;174(24)4684 |
| [DOI] |
|
| 45 | Novel biosynthesized gold nanoparticles as anti-cancer agents against breast cancer: Synthesis, biological evaluation, molecular modelling studies | |
| Satish Kumar Vemuri,Rajkiran Reddy Banala,Sudip Mukherjee,Purushotham Uppula,Subbaiah GPV,Gurava Reddy A.V.,Malarvilli T. |
| Materials Science and Engineering: C.2019;99(24)417 |
| [DOI] |
|
| 46 | An update on the management of breast cancer in Africa | |
| V. Vanderpuye,S. Grover,N. Hammad,N. PoojaPrabhakar,H. Simonds,F. Olopade,D. C. Stefan |
| Infectious Agents and Cancer.2017;12(1)417 |
| [DOI] |
|
| 47 | Risk Factors for Breast Cancer and Expression of Insulin-Like Growth Factor-2 (IGF-2) in Women with Breast Cancer in Wuhan City, China | |
| Jun Qiu,Rong Yang,Yanhua Rao,Yukai Du,Fatch W. Kalembo,Kamyar Afarinkia |
| PLoS ONE.2012;7(5)e36497 |
| [DOI] |
|
| 48 | Risk Factors for Breast Cancer and Expression of Insulin-Like Growth Factor-2 (IGF-2) in Women with Breast Cancer in Wuhan City, China | |
| Adnan Aydiner |
| PLoS ONE.2019;7(5)463 |
| [DOI] |
|
| 49 | Dual cancer targeting using estrogen functionalized chitosan nanoparticles loaded with doxorubicin-estrone conjugate: A quality by design approach | |
| Balak Das Kurmi,Rishi Paliwal,Shivani Rai Paliwal |
| International Journal of Biological Macromolecules.2020;164(5)2881 |
| [DOI] |
|
| 50 | Insulin-Like Growth Factor Receptor I (IGF-IR) and Vascular Endothelial Growth Factor Receptor 2 (VEGFR-2) Are Expressed on the Circulating Epithelial Tumor Cells of Breast Cancer Patients | |
| Monika Pizon,Dorothea Sonja Zimon,Ulrich Pachmann,Katharina Pachmann,Mohammad O. Hoque |
| PLoS ONE.2013;8(2)e56836 |
| [DOI] |
|
| 51 | Investigating the association of vascular endothelial growth factor polymorphisms with breast cancer: a Moroccan case–control study | |
| Jalila Rahoui,Abdelilah Laraqui,Yassir Sbitti,Nadia Touil,Azeddine Ibrahimi,Brahim Ghrab,Abderrahman Al Bouzidi,Driss Moussaoui Rahali,Mohamed Dehayni,Mohamed Ichou,Fatima Zaoui,Saad Mrani |
| Medical Oncology.2014;31(9)e56836 |
| [DOI] |
|
| 52 | A review of nanomaterials from synthetic and natural molecules for prospective breast cancer nanotherapy | |
| Pankaj Kumar,Bharti Mangla,Shamama Javed,Waquar Ahsan,Pankaj Musyuni,Durgaramani Sivadasan,Saad S. Alqahtani,Geeta Aggarwal |
| Frontiers in Pharmacology.2023;14(9)e56836 |
| [DOI] |
|
| 53 | Exosomal-mediated transfer of OIP5-AS1 enhanced cell chemoresistance to trastuzumab in breast cancer via up-regulating HMGB3 by sponging miR-381-3p | |
| Qiang Yu,Yinmou Li,Shijun Peng,Jing Li,Xianxiong Qin |
| Open Medicine.2021;16(1)512 |
| [DOI] |
|
